Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solana Co Director's Dealing 2022

Feb 18, 2022

32724_dirs_2022-02-18_993ae21d-fdfe-48e1-9972-785652655f9b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2022-02-16

Reporting Person: MATHIESEN JEFFREY S (CFO and Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-16 Class A Common Stock A 8011 $0.00 Acquired 11948 Direct

Footnotes

F1: Grant to the Reporting Person of a stock award under the Issuer's 2018 Omnibus Incentive Plan.